Jin-Chen Yu - Ta Solutions (China) | 人才画像

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 32 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Multiepitope Recognition Technology Promotes the In-Depth Analysis of Antibody‒drug Conjugates

Yutian Lei,Yuan Shen, Feng Chen, Rui He, Zhang, Ying Zhou,Jin-Chen Yu,Jacques Crommen,Zhengjin Jiang,Qiqin Wang

Acta Pharmaceutica Sinica B (2024)

引用0浏览0引用

Phase 1 Study of BAT8006, a Folate Receptor Α Antibody Drug Conjugate with Strong Bystander Effect, in Subjects with Advanced Solid Tumors

Haiyan Jia,Songling Zhang,Yuping Sun,Huifeng Zhang,Jihong Liu,Zhentong Wei,Hong Zhang,Jiajia Mai,Hui Qiu,Jianying Huang,Yehui Shi,Juncheng Wei,Qunxian Rao,Li Sun,An Lin,Jie Tang,Ziyi Fu, Xinlang Zhang, Di Zhong,Jin-Chen Yu

JOURNAL OF CLINICAL ONCOLOGYno. 16 (2024)

引用0浏览0引用

Abstract CT189: A Phase I Study of BAT1006, a Novel Anti-Her2 Antibody, in Patients with Locally Advanced/metastatic Solid Tumors

Xingxing Mei,Weijia Tang,Shuqiang Song,Hao Wang, Chuanqi Cao,Cuiying Feng, Bert E. Thomas,Shengfeng Li,Jin-Chen Yu

Cancer Researchno. 8_Supplement (2023)

引用0浏览0引用

BAT8006, a Novel FRα ADC with Strong Bystander Effect, for the Treatment of Advanced Solid Tumor

Siqi Mai,Xingxing Mei,Weijia Tang, Xin Zhou,Xuekang Qi,Zhi Zhong,Shuoxu Li,Jianjun Fan,Jirong Gan,Binghua Tan, Yao Qi,Yanling Guo,Shengfeng Li,Jin-Chen Yu

CANCER RESEARCHno. 5 (2023)

引用0浏览0引用

BAT8008, a Novel Trop-2 ADC with Strong Bystander Effect, for the Treatment of Trop-2 Positive Cancer

Xingxing Mei,Weijia Tang, Xin Zhou,Xuekang Qi,Siqi Mai,Zhi Zhong,Shuoxu Li,Jianjun Fan,Jirong Gan,Binghua Tan, Yao Qi,Yanling Guo,Jin-Chen Yu,Shengfeng Li

CANCER RESEARCHno. 5 (2023)

引用0浏览0引用

BAT6026, a novel anti-OX40 antibody with enhanced antibody dependent cellular cytotoxicity effect for cancer immunotherapy

Shizhong Liang,Dandan Zheng, Xiong Liu, Xiong Mei, Congcong Zhou, Cuizhen Xiao,Chao Qin,Haitao Yue, Jian Lin,Cuihua Liu,Shengfeng Li,Jin-Chen Yu

FRONTIERS IN ONCOLOGY（2023）

引用0浏览0WOS引用

Abstract P4-01-32: BAT8008, a novel Trop-2 ADC with strong bystander effect, for the treatment of Trop-2 positive cancer

Xingxing Mei,Weijia Tang,Xin Zhou,Xuekang Qi,Siqi Mai,Zhi Zhong,Shuoxu Li,Jianjun Fan,Jirong Gan,Binghua Tan, Yao Qi,Yanling Guo,Jin-Chen Yu,Shengfeng Li

Cancer Researchno. 5_Supplement (2023): P4-01

引用0浏览0引用

A phase I study of BAT1006, a novel anti-HER2 antibody, in patients with locally advanced/metastatic solid tumors

Xingxing Mei,Weijia Tang,Shuqiang Song,Hao Wang, Chuanqi Cao, Cuiying Feng, Bert E. Thomas,Shengfeng Li,Jin-Chen Yu

CANCER RESEARCHno. 8 (2023)

引用0浏览0引用

Abstract P4-01-12: BAT8006, a novel FRα ADC with strong bystander effect, for the treatment of advanced solid tumor

Siqi Mai,xingxing Mei,weijia Tang,Xin Zhou,Xuekang qi,Zhi Zhong,Shuoxu Li,Jianjun fan,Jirong Gan,Binghua Tan, Yao Qi,Yanling Guo,Shengfeng li,Jin-Chen Yu

Cancer Researchno. 5_Supplement (2023): P4-01

引用0浏览0引用

Clinical Efficacy and Safety of the BAT1706 (proposed Bevacizumab Biosimilar) Compared with Reference Bevacizumab in Patients with Advanced Nonsquamous NSCLC: A Randomized, Double-Blind, Phase III Study

Likun Chen, Jose David Gomez Rangel,Timucin Cil,Xingya Li,Irfan Cicin,Yihong Shen, Zhihua Liu,Ozgur Ozyilkan,Bondarenko Igor,Jun Chen,Kostiuk Oleksandr,Zhendong Chen,Helong Zhang, Ziyi Fu, Qingfeng Dong,Shuqiang Song,Jin-Chen Yu,Li Zhang

Cancer medicine（2023）

引用0浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn